Skip to content

miR‑328, miR‑575, miR‑134 and miR‑671‑5p as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of therapeutic outcomes of intravenous immunoglobulin therapy

· 0 citations · 57 references

TL;DR

S serum exosomal miR‑328, miR-575, miR-134 and miR-671-5p may act as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of outcomes of the IVIG therapy by influencing the expression of inflammatory genes.

View source

Similar papers

Open access Aug 2026

A circulating three-miRNA panel (hsa-miR-29b-3p, hsa-miR-19b-3p, hsa-miR-30e-5p) for early-stage ovarian cancer detection: a machine-learning bioinformatics approach

Background Ovarian cancer (OVCA) remains one of the most lethal gynecological malignancies, primarily due to late-stage diagnosis and the lack of reliable early-detection biomarkers. Circulating microRNAs (miRNAs) have emerged as promising non-invasive biomarkers for cancer detection and prognosis. Objective This study...

Ahmed El Hosseiny, Meriem Yagoubi, Ahmed Moustafa et al. · 0 citations
Open access Aug 2026

miR-451a is a differentially expressed blood-based microRNA in newly diagnosed CML identified by high-throughput profiling

microRNAs (miRNAs) are emerging as promising biomarkers in hematological malignancies due to their stability in blood. This study aimed to investigate the differential expression of miRNAs in chronic myeloid leukemia (CML) and evaluate the potential of miR-451a as a candidate whole-blood miRNA marker. We c...

Surbhi Gupta, Nitu Nigam, Abdullah H. Maad et al. · 0 citations
Open access Sep 2026

Circulating miRNAs (135a-5p, 646 AND 1271-5P) in Breast Cancer Diagnosis and Staging: Integrative Network and Functional Analysis

Abstract Introduction: Breast cancer (BC) remains a leading cause of cancer-related mortality among women worldwide. Despite advances in molecular diagnostics, reliable non-invasive biomarkers for early detection and disease staging remain limited. Circulating microRNAs (miRNAs) are promising epigenetic regulators invo...

A. Abdel-Hamed, Marina Barsom, Mahmoud M. Kamel et al. · 0 citations
Open access Aug 2026

Identifying miR-431-5p as a promising candidate biomarker for early-onset severe preeclampsia through integrated bioinformatic and clinical analyses: a retrospective study

Findings suggest that miR-431-5p may serve as a promising candidate biomarker for EOSPE, with its expression was significantly upregulated in both serum and placental tissues of patients with EOSPE.

Jian-Xin Zhang, Hong-Wei Li, Yu-Ping Yan et al. · 0 citations
Sep 2026

Identification of a circulating miR-6838-5p/miR-195-5p signature in invasive ductal breast carcinoma

The miR-6838-5p/miR-195-5p combination represents a promising circulating miRNA signature for invasive ductal breast carcinoma and its consistent discriminatory performance in the discovery cohort and an independent serum cohort supports further evaluation in larger prospective studies.

Mustafa Barış Zeytunlu, Fazilet Esra Incedere Duzdag, Hüseyin Esin et al. · 0 citations
Open access Aug 2026

Prediction of potential biomarkers and therapeutic targets in HIV viremic patients using immune-related circRNA-miRNA-mRNA regulatory networks

This integrative analysis suggests potential circRNA-mediated regulatory mechanisms in HIV infection and highlights potential candidate circRNAs that may serve as biomarkers or therapeutic targets for further investigation.

Negin Faraji, Leila Rouhi, A. Bolhassani et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.